TOKYO, July 26, 2016 (GLOBE NEWSWIRE) -- FRONTEO, Inc. (“FRONTEO”) (Nasdaq: FTEO ) (TSE: 2158 ), a leading provider of international litigation support and big-data analysis services, and FRONTEO Healthcare, Inc. (“FRONTEO Healthcare”), a wholly-owned FRONTEO subsidiary providing medical data analysis solutions, today announced that the Japan Patent Office has recently issued a Notification of Decision to Grant to the company for the AI-based technology that is used to predict patient falls in healthcare facilities.
The necessary procedures of patent registration have already been executed, and the patent is currently pending issuance.
Patent application number: 2015-558257 Registration number: Pending issuance Patent application filing date: November 27, 2015 Priority date: January 26, 2015
The innovative AI-based technology covered by this patent detects signs of patient falls by analyzing the unstructured textual data contained in electronic medical records and day-to-day examination records. The evaluation result, provided by a joint research project the companies conducted with a partner hospital, revealed that this innovative technology could improve fall risk prediction accuracy by up to 30-40% versus conventional methods. Encouraged by the result, FRONTEO and FRONTEO Healthcare anticipate that this technology will significantly reduce the workload of doctors and nurses by cutting down the time and efforts they used to spend on preventing patient falls.
At the International Modern Hospital Show 2016 held from July 13 th through the 15 th , FRONTEO showcased the prototype of the “Patient Fall Prediction System” which is supported by the AI-based technology in this patent and powered by FRONTEO’s AI-based engine “KIBIT.”
"We believe that this patent is a testament to the superior innovation that underlies the highly accurate document analytics provided by FRONTEO," stated FRONTEO Chairman and Chief Executive Officer Masahiro Morimoto. "In this advanced digital age, when the processing of vast volumes of data is necessary, our data analytics solutions are expanding into increasingly important business fields, such as healthcare, business intelligence and marketing. By further honing our AI-based technologies and extending our portfolio of intellectual properties, FRONTEO will continue to provide highly sophisticated services and deliver a better future to people worldwide."
About FRONTEO, Inc. FRONTEO, Inc. (“FRONTEO”) (Nasdaq: FTEO ) (TSE: 2158 ) supports the analysis of big data based on behavior informatics by utilizing its technology, "KIBIT". FRONTEO's KIBIT technology is driven by FRONTEO AI based on knowledge acquired through its litigation support services. The KIBIT incorporates experts' tacit knowledge, including their experiences and intuitions, and utilizes that knowledge for big data analysis. FRONTEO continues to expand its business operations by applying KIBIT to new fields such as healthcare and marketing. FRONTEO was founded in 2003 as a provider of e-discovery and international litigation support services. These services include the preservation, investigation and analysis of evidence materials contained in electronic data, and computer forensic investigation. FRONTEO provides e-discovery and litigation support by making full use of its data analysis platform, "Lit i View ® ", and its Predictive Coding technology adapted to Asian languages. The company name was changed from UBIC, Inc. to FRONTEO, Inc. as of July 1, 2016.
For more information about FRONTEO, contact usinfo@fronteo.com or visit http://www.fronteo.com/global/
Safe Harbor Statement This announcement contains forward-looking statements. These forward-looking statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the amount of data that FRONTEO expects to manage this year and the potential uses for FRONTEO's new service in intellectual property-related litigation, contain forward-looking statements. FRONTEO may also make written or oral forward-looking statements in its reports filed with, or furnished to, the U.S. Securities and Exchange Commission, in its annual reports to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about FRONTEO's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: FRONTEO's goals and strategies; FRONTEO's expansion plans; the expected growth of the data center services market; expectations regarding demand for, and market acceptance of, FRONTEO's services; FRONTEO's expectations regarding keeping and strengthening its relationships with customers; FRONTEO's plans to invest in research and development to enhance its solution and service offerings; and general economic and business conditions in the regions where FRONTEO provides solutions and services. Further information regarding these and other risks is included in FRONTEO's reports filed with, or furnished to the Securities and Exchange Commission. FRONTEO does not undertake any obligation to update any forward-looking statement, except as required under applicable law. All information provided in this press release and in the attachments is as of the date of this press release, and FRONTEO undertakes no duty to update such information, except as required under applicable law.
CONTACT: FRONTEO Global PR FRONTEO USA, Inc. Tel: (212) 924-8242 global_pr@fronteo.com
